BioMarin resevwa opinyon CHMP pozitif an Ewòp pou terapi jenetik Valoctocogene Roxaparvovec pou trete adilt ki gen emofili A grav.

BioMarin resevwa opinyon CHMP pozitif an Ewòp pou terapi jenetik Valoctocogene Roxaparvovec pou trete adilt ki gen emofili A grav.
Imaj

Please enable the javascript to submit this form

Sipòte pa sibvansyon edikasyon bay Bayer, BioMarin, CSL Behring, Freeline Therapeutics Limited, Pfizer Inc., Spark Therapeutics, ak uniQure, Inc.

Esansyèl SSL